Risk Factors and Screening for Chronic Kidney Disease

Advances in Chronic Kidney Disease

Volumn 17, Issue 3, 2010, Pages 237-245

  Vassalotti, Joseph A ^a,b   Fox, Chester H ^c   Becker, Bryan N ^d  

^a NATIONAL KIDNEY FOUNDATION   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL DECISION MAKING; COMMUNITY CARE; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; ETHNICITY; FAMILY HISTORY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MASS SCREENING; MICROALBUMINURIA; PATIENT EDUCATION; PATIENT REFERRAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGING; CHRONIC DISEASE; COMMUNITY MEDICINE; DECISION SUPPORT TECHNIQUES; DIABETES COMPLICATIONS; EARLY DIAGNOSIS; HUMANS; HYPERTENSION; KIDNEY DISEASES; MASS SCREENING; MEDICARE; RISK FACTORS; UNITED STATES;

EID: 77951637796     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.03.003     Document Type: Review

References (47)

1. Plantinga L.C., Boulware L.E., Coresh J., et al. Patient awareness of chronic kidney disease: Trends and predictors. Arch Intern Med 168 (2008) 2268-2275
2. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, 2009 edn. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
3. Fox C.H., Swanson A., Kahn L.S., Glaser K., et al. Improving chronic kidney disease care in primary care practices: An upstate New York practice-based research network (UNYNET) study. J Am Board Fam Med 21 (2008) 522-530
4. Stevens L.A., Fares G., Fleming J., et al. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 16 (2005) 2439-2448
5. Wilson J.M., and Jungner G. Principles and Practice of Screening for Disease. France (1968), World Health Organization 1-163
6. Guide to Clinical Preventive Services. Rockville, MD: Agency for Healthcare Research and Quality, 2009. AHRQ Publication No. 09-IP006. Available at: http://www.ahrq.gov/clinic/pocketgd.htm
7. Powe N.R., and Boulware L.E. Population-based screening for CKD. Am J Kidney Dis 53 S3 (2009) S64-S70
8. Boulware L.E., Jaar B.G., Tarver-Carr M.E., et al. Screening for proteinuria in U.S. adults - a cost effective analysis. JAMA 290 (2003) 3101-3014
9. Hoerger T.J., Wittenborn J.S., Segel J.E., et al. Centers for Disease Control and Prevention CKD Initiative. A Health Policy Model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis 55 (2010) 463-473
10. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl 1 (2002) S1-S266
11. Epstein A.M., Ayanian J.Z., Keogh J.H., et al. Racial disparities in access to renal transplantation-clinically appropriate or due to underuse or overuse?. N Engl J Med 343 (2000) 1537-1544
12. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 33 Suppl 1 (2010) S1-S100
13. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 (2003) 2560-2572
14. Collins A.J., Vassalotti J.A., Changchun W., et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis 53 Suppl 3 (2009) S71-S85
15. Hallan S.I., Dahl K., Oien C.M., et al. Screen strategies for chronic kidney disease in the general population: Follow-up of cross sectional health survey. BMJ 333 (2006) 1047-1051
16. Kiberd B.A., and Jindal K.K. Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation. BMJ 311 (1995) 1595-1599
17. Palmer A.J., Weiss C., Sendi P.P., et al. The cost effectiveness of different management strategies for type 1 diabetes. Diabetologia 43 (2000) 13-26
18. Brosius III F.C., Hostetter T.H., Kelepouris E., et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in collaboration with the National Kidney Foundation. Circulation 114 (2006) 1083-1087
19. Lei H.H., Perneger T.V., Klag M.J., et al. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol 9 (1998) 1270-1276
20. Freedman B.I., Volkova N.V., Satko S.G., et al. Population-based screening for family history of end-stage renal disease among incident dialysis patients. Am J Nephrol 25 (2005) 529-535
21. Jurkovitz C., Hylton T.N., and McClellan W.M. Prevalence of family history of kidney disease and perception of risk for kidney disease: A population-based study. Am J Kidney Dis 46 (2005) 11-17
22. Daumit G.L., and Powe N.R. Factors influencing access to cardiovascular procedures in patients with chronic kidney disease: Race, sex, and insurance. Semin Nephrol 21 (2001) 367-376
23. Vassalotti J.A., Li S., McCullough P.A., et al. Kidney Early Evaluation Program: A Community-Based Screening Approach to Address Disparities in Chronic Kidney Disease. Semin Nephrol 30 (2010) 66-72
24. Freedman B.I., Hicks P.J., Bostrom M.A., et al. Polymorphisms in the non-muscle myosin heavy chain 9 (MYH9) gene are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int 75 (2009) 736-745
25. Vassalotti J.A., Stevens L.A., and Levey A.S. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 50 (2007) 169-180
26. Levey A.S., Atkins R., Coresh J., et al. Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72 (2007) 247-259
27. Stevens L.A., Padala S., and Levey A.S. Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens 19 (2010) 298-307
28. Bang H., Vuppururi S., Shoham D.A., et al., Screening for Occult Renal Disease (SCORED). A simple prediction model for chronic kidney disease. Arch Intern Med 167 (2007) 374-381
29. Bennett W.M., Henrich W.L., and Stoff J.S. The renal effects of nonsteroidal anti-inflammatory drugs: Summary and recommendations. NSAID use and progression of chronic kidney disease. Am J Kidney Dis 28 1Suppl 1 (1996) S56-S62
30. Heher E.C., Thier S.O., Rennke H., et al. Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation. Clin J Am Soc Nephrol 3 (2008) 1494-1503
31. Boulware L.E., Troll M.U., Jarr B.G., et al. Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis 48 (2006) 192-204
32. Agrawal V., Ghosh A.K., Barnes M.A., et al. Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: A national online survey. Am J Kidney Dis 52 (2008) 1061-1069
33. Fox C.H., Brooks A., Zayas L.E., et al. Primary care physicians' knowledge and practice patterns in the treatment of chronic kidney disease: An Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med 19 (2006) 54-61
34. Østbye T., Yarnall K.S., Krause K.M., et al. Is there time for management of patients with chronic diseases in primary care?. Ann Fam Med 3 (2005) 209-214
35. Yarnall K.S., Pollak K.I., Østbye T., et al. Primary care: Is there enough time for prevention?. Am J Public Health 93 (2003) 635-641
36. Pham H.H., O'Malley A.S., Bach P.B., et al. Primary care physicians' links to other physicians through Medicare patients: The scope of care coordination. Ann Intern Med 150 (2009) 236-242
37. Kinchen K.S., Sadler J., Fink N., et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137 (2002) 479-486
38. Chan M.R., Dall A.T., Fletcher K.E., et al. Outcomes in patients with chronic kidney disease referred late to nephrologists: A meta-analysis. Am J Med 120 (2007) 1063-1070
39. Campbell J.D., Ewigman B., Hoskawa M., et al. The timing of referral of patients with end-stage renal disease. Dial Transplant 18 (1989) 660-686
40. Shahinian VB., and Saran R. The role of primary care in the management of the chronic kidney disease population. ACKD 17 (2010) 246-253
41. Patel T.G., Pogach L.M., and Barth R.H. CKD screening and management in the Veterans Health Administration: The impact of system organization and an innovative electronic record. Am J Kidney Dis 53 3 Suppl 3 (2009) S78-S85
42. Rutkowski M., Mann W., Derose S., et al. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente. Am J Kidney Dis 53 3 Suppl 3 (2009) S86-S99
43. Wyatt C., Konduri V., Eng J., et al. Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis 49 (2007) 634-641
44. McClellan W.M., and Flanders W.D. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 14 7 Suppl 2 (2003) S65-S70
45. Vassalotti J.A., Li S., Chen S.C., et al. Screening populations at increased risk of CKD: The Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 53 3 Suppl 3 (2009) S107-S114
46. Collins A.J., Vassalotti J., Li S., et al. Prevalence and Control of CVD Risk Factors among Initial CHERISH Participants with CKD. J Am Soc Nephrol 1602A (2009)
47. Jaar B.G., Khatib R., Platinga L., et al. Principles for screening for chronic kidney disease. Clin J Am Soc Nephrol 3 (2008) 601-609